Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shareholder Activists
Biotech
AIM Immunotech once again battles activist uprising
A persistent group of activist investors is suing AIM Immunotech after its proposed slate of new board members was rejected.
Max Bayer
Aug 29, 2023 10:50am
CytoDyn ousts CEO Pourhassan after a wild year
Jan 26, 2022 10:30am
CytoDyn's shareholders have a plan to get leronlimab approved
Sep 24, 2021 11:37am
Wildcat attempts coup on Sorrento, accuses it of squandering assets
May 6, 2016 9:42am
